Article information
Full text is only aviable in PDF
References
[1.]
E. Herrera-Acosta, G. Martín-Ezquerra, M. Iglesias, P. Umbert.
Erupción acneiforme secundaria a cetuximab.
Actas Dermosifiliogr, 96 (2005), pp. 252-254
[2.]
A. Kimyai-Asadi, M.H. Jih.
Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors.
Arch Dermatol, 138 (2002), pp. 129-131
[3.]
L. Walon, C. Gilbeau, J.M. Lachapelle.
Acneiform eruptions induced by cetuximab.
Ann Dermatol Venereol, 130 (2003), pp. 443-446
[4.]
G. Jul, A. González-de Arriba, E. Daudén.
Efectos secundarios de los inhibidores del receptor del factor de crecimiento epidérmico.
Actas Dermosifiliogr, 97 (2006), pp. 296-310
[5.]
Z. Martínez de Lagrán, J.A. Ratón, O. Lasa.
Erupción acneiforme por inhibidores del receptor de crecimiento epidérmico.
Actas Dermosifilogr, 96 (2005), pp. 450-454
[6.]
N. Sandwich.
Tolerability in patients receiving treatment in everyday clinical practice.
Br J Cancer, 89 (2003), pp. S9-S14
[7.]
M.C. Fariña, L. Requena, M. Dómine, M.L. Soriano, L. Estévez, A. Barat.
Histopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudomalignancy.
J Cutan Pathol, 25 (1998), pp. 559-562
[8.]
T.D. Horn, D.J. Burk, J.E. Karp, A.F. Hood.
Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption.
Arch Dermatol, 127 (1991), pp. 49
[9.]
R. Valks, E. Vargas, E. Muñoz, J. Fernández-Herrera, A. García Díez, J. Fraga.
Dermal infiltrate of enlarged macrophages in patients receiving chemotherapy.
J Cutan Pathol, 25 (1998), pp. 259
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
